CDKN2A and cholangiocarcinoma: Additionally, p16INK4a showed a sensitivity of 53.6% and a specificity of 93.8% for discriminating between CCA and benign illnesses, whereas p14ARF had a sensitivity of 46.2% and a specificity of 96.9% [8].